Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hemorrhagic Shock: later-stage trial registry
2 of 4 indexed Hemorrhagic Shock trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 2 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Hemorrhagic Shock: 4 US clinical trials tracked, 2 recruiting.
Hemorrhagic Shock is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Philip Spinella, running 1 of these trials.
Enrollment posture brief
Registry condition hemorrhagic-shock
OPEN 2 | RECR 50% | LATE 2 | EARLY 0 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Hemorrhagic Shock lists 2 open slots (50% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hemorrhagic Shock on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hemorrhagic Shock is recruiting above its size-band peers.
2 of 4 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children
Philip Spinella
NCT06070350
REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam
Arsenal Medical
NCT02880163
Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial
Jason Sperry
NCT04684719
Development of an Algorithm for Prediction of Onset of Hemodynamic Instability in Humans
University of California, Irvine
NCT00581204
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Hemorrhagic Shock records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hemorrhagic Shock trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hemorrhagic Shock page
4 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Hemorrhagic Shock trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Philip Spinella sponsors the most Hemorrhagic Shock trials on record, review their full trial history before evaluating a specific study. See Philip Spinella's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hemorrhagic Shock condition card totals 4 registered trials; most-linked intervention Near-Infrared Diffuse Optical Spectroscopy; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.